Home|Journals|Articles by Year|Audio Abstracts
 

Short Communication



In Opportunity Losses for Non-COVID-19 Patients Due to Restricted Access Healthcare

Slobodan M. Jankovic.




Abstract

With this letter, I would like to draw attention to the necessity of investing in extensive epidemiological and pharmacoeconomic research on the benefits and harms (costs) of interventions and measures taken in the fight against the COVID 19 pandemic, so that rational decisions can be made in close future.

Key words: EASE, Communication of research results, Science editing, Science publishing






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.